Direct immunofluorescence on tissue biopsies
Materials Required
/
Principle
Direct immunofluorescence (DIF) detects tissue-bound immunoreactants in biopsy sections by applying fluorescein-labeled antibodies directly to frozen tissue; antigen-antibody binding is visualized as fluorescence under a fluorescence microscope, and the anatomic pattern of IgG, IgA, IgM, C3, or fibrin/fibrinogen deposition supports diagnosis of immune-mediated skin, mucosal, and renal disease[1][2][3]. Classic interpretive examples include intercellular epidermal staining in pemphigus, linear basement-membrane-zone staining in pemphigoid-spectrum disorders, granular IgA in dermal papillae in dermatitis herpetiformis, and glomerular immune deposits in renal biopsies[2][3][4].
MCE has not independently verified the accuracy of these methods. They are for reference only.
Experimental Materials
• Use phosphate-buffered saline or normal saline for short-term biopsy transport and washing; Michel’s transport medium can preserve tissue-fixed immunoglobulins in skin biopsies when immediate freezing is not available[5][6].
• Use an embedding medium suitable for cryosectioning and prepare frozen tissue sections for DIF; renal DIF is preferentially performed on fresh frozen tissue, while protease-treated paraffin sections are supported only as a salvage approach when frozen renal tissue is inadequate[7].
• Use fluorescein-labeled anti-human IgG, IgA, IgM, C3, and fibrin/fibrinogen conjugates for cutaneous or mucosal DIF panels; renal biopsy panels commonly include fluorescein-labeled antibodies against immunoglobulins, complement, and light chains when evaluating immune deposits[2][3][7].
• Use a cryostat for frozen sectioning, a humid chamber for antibody incubation, Coplin jars or equivalent vessels for washing, and a fluorescence microscope for detecting fluorescein signal in the relevant tissue compartment[2][3][8].
• Use an embedding medium suitable for cryosectioning and prepare frozen tissue sections for DIF; renal DIF is preferentially performed on fresh frozen tissue, while protease-treated paraffin sections are supported only as a salvage approach when frozen renal tissue is inadequate[7].
• Use fluorescein-labeled anti-human IgG, IgA, IgM, C3, and fibrin/fibrinogen conjugates for cutaneous or mucosal DIF panels; renal biopsy panels commonly include fluorescein-labeled antibodies against immunoglobulins, complement, and light chains when evaluating immune deposits[2][3][7].
• Use a cryostat for frozen sectioning, a humid chamber for antibody incubation, Coplin jars or equivalent vessels for washing, and a fluorescence microscope for detecting fluorescein signal in the relevant tissue compartment[2][3][8].
Experimental Procedure
• Collect a biopsy from an anatomically appropriate site for the suspected disease; for autoimmune blistering disease, perilesional skin or mucosa is generally preferred, while active ulcerated or detached epidermis can reduce diagnostic yield[3][4].
• Transport tissue promptly for DIF; published skin-biopsy evidence supports normal saline for 24 hours, while Michel’s medium preserves tissue-fixed immunoglobulins when transport without immediate freezing is required[5][6].
• Freeze the biopsy and prepare cryosections; published dermatology protocols describe DIF as a one-step procedure on frozen sections, and renal pathology literature identifies frozen tissue as the preferred substrate for renal biopsy immunofluorescence[2][7].
• Air-dry cryosections before staining, because wet cryosections may detach during washing; incubate sections with appropriately diluted fluorescein-labeled conjugates to IgG, IgA, IgM, C3, and fibrin/fibrinogen in a moist chamber at room temperature, with published dermatology methods reporting 1-2 hours of incubation[2][3][9].
• Wash stained sections with buffer after conjugate incubation, mount the sections with a fluorescence-compatible mounting medium, and examine promptly by fluorescence microscopy to record the location, pattern, and intensity of specific staining[2][3][8].
• For renal biopsies lacking adequate frozen tissue, pronase- or proteinase-treated paraffin immunofluorescence may be used as a salvage method, but it should not replace frozen-section DIF when adequate frozen renal tissue is available[7].
• Interpret DIF by integrating the class of immunoreactant, the anatomic site of deposition, and staining pattern; examples include intercellular epidermal IgG/C3 in pemphigus, linear basement-membrane-zone IgG/C3 in pemphigoid-spectrum disease, granular papillary dermal IgA in dermatitis herpetiformis, and glomerular immune-complex or light-chain staining patterns in renal disease[2][3][4][7].
• Use clinical and histopathologic correlation because DIF is an adjunct rather than a stand-alone diagnosis in many disorders; published studies report that DIF improves classification of immune-mediated dermatologic disease when combined with clinical and routine histology findings[3][9].
• Transport tissue promptly for DIF; published skin-biopsy evidence supports normal saline for 24 hours, while Michel’s medium preserves tissue-fixed immunoglobulins when transport without immediate freezing is required[5][6].
• Freeze the biopsy and prepare cryosections; published dermatology protocols describe DIF as a one-step procedure on frozen sections, and renal pathology literature identifies frozen tissue as the preferred substrate for renal biopsy immunofluorescence[2][7].
• Air-dry cryosections before staining, because wet cryosections may detach during washing; incubate sections with appropriately diluted fluorescein-labeled conjugates to IgG, IgA, IgM, C3, and fibrin/fibrinogen in a moist chamber at room temperature, with published dermatology methods reporting 1-2 hours of incubation[2][3][9].
• Wash stained sections with buffer after conjugate incubation, mount the sections with a fluorescence-compatible mounting medium, and examine promptly by fluorescence microscopy to record the location, pattern, and intensity of specific staining[2][3][8].
• For renal biopsies lacking adequate frozen tissue, pronase- or proteinase-treated paraffin immunofluorescence may be used as a salvage method, but it should not replace frozen-section DIF when adequate frozen renal tissue is available[7].
• Interpret DIF by integrating the class of immunoreactant, the anatomic site of deposition, and staining pattern; examples include intercellular epidermal IgG/C3 in pemphigus, linear basement-membrane-zone IgG/C3 in pemphigoid-spectrum disease, granular papillary dermal IgA in dermatitis herpetiformis, and glomerular immune-complex or light-chain staining patterns in renal disease[2][3][4][7].
• Use clinical and histopathologic correlation because DIF is an adjunct rather than a stand-alone diagnosis in many disorders; published studies report that DIF improves classification of immune-mediated dermatologic disease when combined with clinical and routine histology findings[3][9].
Troubleshooting
Problem: Weak or negative DIF in a clinically suspected blistering disorder.
• Possible Cause: Biopsy from ulcerated, detached, or non-representative tissue.• Literature-supported Solution: Repeat biopsy from perilesional skin or mucosa rather than eroded tissue when clinically feasible[3][4].
Problem: High background fluorescence.
• Possible Cause: Transport or processing conditions that retain nonspecific dermal or epidermal IgG background.• Literature-supported Solution: For skin biopsies that can be processed within 24 hours, normal saline transport reduced background fluorescence compared with liquid nitrogen or Michel’s medium in a matched-biopsy study[6].
Problem: Frozen renal biopsy has no glomeruli for DIF.
• Possible Cause: Inadequate cortical sampling in tissue allocated for frozen immunofluorescence.• Literature-supported Solution: Perform immunofluorescence on protease-treated paraffin renal tissue as a salvage method, while recognizing reduced sensitivity for some deposits compared with frozen tissue[7].
References:
- [1]. Coons AH, et al. Localization of antigen in tissue cells; improvements in a method for the detection of antigen by means of fluorescent antibody. J Exp Med. 1950;91(1):1-13. [Content Brief]
- [2]. Chhabra S, et al. Immunofluorescence in dermatology. Indian J Dermatol Venereol Leprol. 2012;78(6):677-691. [Content Brief]
- [3]. Shetty VM, et al. Utility of immunofluorescence in dermatology. Indian Dermatol Online J. 2017;8(1):1-8. [Content Brief]
- [4]. Mahmood MN. Direct Immunofluorescence of Skin and Oral Mucosa: Guidelines for Selecting the Optimum Biopsy Site. Dermatopathology (Basel). 2024;11(1):52-61. [Content Brief]
- [5]. Michel B, et al. Preservation of tissue-fixed immunoglobulins in skin biopsies of patients with lupus erythematosus and bullous diseases--preliminary report. J Invest Dermatol. 1972;59(6):449-452. [Content Brief]
- [6]. Vodegel RM, et al. Enhanced diagnostic immunofluorescence using biopsies transported in saline. BMC Dermatol. 2004;4:10. [Content Brief]
- [7]. Nasr SH, et al. Immunofluorescence on pronase-digested paraffin sections: a valuable salvage technique for renal biopsies. Kidney Int. 2006;70(12):2148-2151. [Content Brief]
- [8]. Im K, et al. An Introduction to Performing Immunofluorescence Staining. Methods Mol Biol. 2019;1897:299-311. [Content Brief]
- [9]. Mysorekar VV, et al. Role of direct immunofluorescence in dermatological disorders. Indian Dermatol Online J. 2015;6(3):172-180. [Content Brief]
LinkedIn
Researchgate
Instagram
X
Facebook
WhatsApp
Reddit
Mail